Replies to post #416150 on Anavex Life Sciences Corp (AVXL)

[sokol]

If it were me, I would put forth a push to seek approval in Australia, the EU and Japan (after landing a partnership in Japan) first and foremost because of a bias in favor of big pharma in the US and due to surrogate biomarker issues. If approval overseas is a big hit, the US will fall in line.